Subtle conformational changes between CX3CR1 genetic variants as revealed by resonance energy transfer assays

FASEB Journal

Volumn 24, Issue 11, 2010, Pages 4585-4598

  Darbandi Tehrani, Kévin ^a,b   Hermand, Patricia ^a,b   Carvalho, Stéphanie ^a,b,e   Dorgham, Karim ^a,b   Couvineau, Alain ^c,d   Lacapère, Jean Jacques ^c,d   Combadière, Christophe ^a,b   Deterre, Philippe ^a,b  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e ECOLE NORMALE SUPÉRIEURE   (France)

Author keywords

Adherence; BRET; Chemokine; FRET; GPCR

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; G PROTEIN COUPLED RECEPTOR;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CONFORMATIONAL TRANSITION; FLOW CYTOMETRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MOLECULAR MODEL; POINT MUTATION; PRIORITY JOURNAL;

CELL LINE; CHEMOKINE CX3CL1; FLOW CYTOMETRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC VARIATION; HUMANS; MODELS, MOLECULAR; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; REPRODUCIBILITY OF RESULTS;

EID: 78649886014     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-156612     Document Type: Article

References (99)

1. Luster, A. D., Alon, R., and von Andrian, U. H. (2005) Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6, 1182-1190
2. Langer, H. F., and Chavakis, T. (2009) Leukocyte-endothelial interactions in inflammation. J. Cell. Mol. Med. 13, 1211-1220
3. Charo, I. F., and Ransohoff, R. M. (2006) The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354, 610-621
4. Lazennec, G., and Richmond, A. (2010) Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol. Med. 16, 133-144
5. Combadière, B., Combadière, C., and Deterre, P. (2007) Les chimiokines: un réseau sophistiqué de guidage cellulaire. Med. Sci. (Paris) 23, 173-179
6. Ransohoff, R. M. (2009) Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 31, 711-721
7. Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., and Schall, T. J. (1997) A new class of membrane-bound chemokine with a CX3C motif. Nature 385, 640-644
8. Matloubian, M., David, A., Engel, S., Ryan, J. E., and Cyster, J. G. (2000) A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol. 1, 298-304
9. Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J., and Yoshie, O. (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91, 521-530
10. Combadiere, C., Salzwedel, K., Smith, E. D., Tiffany, H. L., Berger, E. A., and Murphy, P. M. (1998) Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. J. Biol. Chem. 273, 23799-23804
11. Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., Lee, J.-C., Cook, D. N., Jung, S., Lira, S. A., Littman, D. R., and Ransohoff, R. M. (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9, 917-924
12. Combadiere, C., Feumi, C., Raoul, W., Keller, N., Rodero, M., Pezard, A., Lavalette, S., Houssier, M., Jonet, L., Picard, E., Debre, P., Sirinyan, M., Deterre, P., Ferroukhi, T., Cohen, S. Y., Chauvaud, D., Jeanny, J. C., Chemtob, S., Behar-Cohen, F., and Sennlaub, F. (2007) CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J. Clin. Invest. 117, 2920-2928
13. Lavergne, E., Combadiere, B., Bonduelle, O., Iga, M., Gao, J. L., Maho, M., Boissonnas, A., Murphy, P. M., Debre, P., and Combadiere, C. (2003) Fractalkine mediates natural killer-dependent antitumor responses in vivo. Cancer Res. 63, 7468-7474
14. Yu, Y. R., Fong, A. M., Combadiere, C., Gao, J. L., Murphy, P. M., and Patel, D. D. (2007) Defective antitumor responses in CX3CR1-deficient mice. Int. J. Cancer 121, 316-322
15. Feng, L., Chen, S., Garcia, G. E., Xia, Y., Siani, M. A., Botti, P., Wilson, C. B., Harrison, J. K., and Bacon, K. B. (1999) Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. Kidney Int. 56, 612-620
16. Moatti, D., Faure, S., Fumeron, F., Amara, M., Seknadji, P., McDermott, D. H., Debre, P., Aumont, M. C., Murphy, P. M., de Prost, D., and Combadiere, C. (2001) Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97, 1925-1928
17. McDermott, D. H., Fong, A. M., Yang, Q., Sechler, J. M., Cupples, L. A., Merrell, M. N., Wilson, P. W., D'Agostino, R. B., O'Donnell, C. J., Patel, D. D., and Murphy, P. M. (2003) Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J. Clin. Invest. 111, 1241-1250
18. Hermand, P., Pincet, F., Carvalho, S., Ansanay, H., Trinquet, E., Daoudi, M., Combadiere, C., and Deterre, P. (2008) Functional adhesiveness of the CX3CL1 chemokine requires its aggregation: role of the transmembrane domain. J. Biol. Chem. 283, 30225-30234
19. Faure, S., Meyer, L., Costagliola, D., Vaneensberghe, C., Genin, E., Autran, B., Delfraissy, J. F., McDermott, D. H., Murphy, P. M., Debre, P., Theodorou, I., and Combadiere, C. (2000) Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science 287, 2274-2277
20. McDermott, D. H., Colla, J. S., Kleeberger, C. A., Plankey, M., Rosenberg, P. S., Smith, E. D., Zimmerman, P. A., Combadiere, C., Leitman, S. F., Kaslow, R. A., Goedert, J. J., Berger, E. A., O'Brien, T. R., and Murphy, P. M. (2000) Genetic polymorphism in CX3CR1 and risk of HIV disease. Science 290, 2031
21. McDermott, D. H., Halcox, J. P., Schenke, W. H., Waclawiw, M. A., Merrell, M. N., Epstein, N., Quyyumi, A. A., and Murphy, P. M. (2001) Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ. Res. 89, 401-407
22. Nadif, R., Mintz, M., Rivas-Fuentes, S., Jedlicka, A., Lavergne, E., Rodero, M., Kauffmann, F., Combadiere, C., and Kleeberger, S. R. (2006) Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis. Cytokine 33, 171-178
23. Tremblay, K., Lemire, M., Provost, V., Pastinen, T., Renaud, Y., Sandford, A. J., Laviolette, M., Hudson, T. J., and Laprise, C. (2006) Association study between the CX3CR1 gene and asthma. Genes Immun. 7, 632-639
24. Rodero, M., Marie, Y., Coudert, M., Blondet, E., Mokhtari, K., Rousseau, A., Raoul, W., Carpentier, C., Sennlaub, F., Deterre, P., Delattre, J. Y., Debre, P., Sanson, M., and Combadiere, C. (2008) Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma. J. Clin. Oncol. 26, 5957-5964
25. Lavergne, E., Labreuche, J., Daoudi, M., Debre, P., Cambien, F., Deterre, P., Amarenco, P., and Combadiere, C. (2005) Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease. Arterioscler. Thromb. Vasc. Biol. 25, 847-853
26. Hattori, H., Ito, D., Tanahashi, N., Murata, M., Saito, I., Watanabe, K., and Suzuki, N. (2005) T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease. Neurosci. Lett. 374, 132-135
27. Daoudi, M., Lavergne, E., Garin, A., Tarantino, N., Debre, P., Pincet, F., Combadiere, C., and Deterre, P. (2004) Enhanced adhesive capacities of the naturally occurring Ile249-Met280 variant of the chemokine receptor CX3CR1. J. Biol. Chem. 279, 19649-19657
28. Davis, C. N., and Harrison, J. K. (2006) Proline 326 in the C terminus of murine CX3CR1 prevents G-protein and phosphatidylinositol 3-kinase-dependent stimulation of akt and extracellular signal-regulated kinase in Chinese hamster ovary cells. J. Pharmacol. Exp. Ther. 316, 356-363
29. Levoye, A., Jockers, R., Ayoub, M. A., Delagrange, P., Savaskan, E., and Guillaume, J. L. (2006) Are G protein-coupled receptor heterodimers of physiological relevance? Focus on melatonin receptors. Chronobiol. Int. 23, 419-426
30. Bulenger, S., Marullo, S., and Bouvier, M. (2005) Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol. Sci. 26, 131-137
31. Bouvier, M. (2001) Oligomerization of G-protein-coupled transmitter receptors. Nat. Rev. Neurosci. 2, 274-286
32. Milligan, G., Ramsay, D., Pascal, G., and Carrillo, J. J. (2003) GPCR dimerisation. Life Sci. 74, 181-188
33. Pfleger, K. D., and Eidne, K. A. (2005) Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells. Biochem. J. 385, 625-637
34. Fung, J. J., Deupi, X., Pardo, L., Yao, X. J., Velez-Ruiz, G. A., Devree, B. T., Sunahara, R. K., and Kobilka, B. K. (2009) Ligand-regulated oligomerization of beta(2)-adrenoceptors in a model lipid bilayer. EMBO J. 28, 3315-3328
35. Garin, A., Tarantino, N., Faure, S., Daoudi, M., Lecureuil, C., Bourdais, A., Debre, P., Deterre, P., and Combadiere, C. (2003) Two novel fully functional isoforms of CX3CR1 are potent HIV coreceptors. J. Immunol. 171, 5305-5312
36. Tournamille, C., Le Van Kim, C., Gane, P., Blanchard, D., Proudfoot, A. E., Cartron, J. P., and Colin, Y. (1997) Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulfide bond is required for ligand binding. J. Biol. Chem. 272, 16274-16280
37. McVey, M., Ramsay, D., Kellett, E., Rees, S., Wilson, S., Pope, A. J., and Milligan, G. (2001) Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human delta-opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J. Biol. Chem. 276, 14092-14099
38. Ayoub, M. A., Couturier, C., Lucas-Meunier, E., Angers, S., Fossier, P., Bouvier, M., and Jockers, R. (2002) Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J. Biol. Chem. 277, 21522-21528
39. Mercier, J. F., Salahpour, A., Angers, S., Breit, A., and Bouvier, M. (2002) Quantitative assessment of beta 1 and beta 2-adrenergic receptor homo and hetero-dimerization by bioluminescence resonance energy transfer. J. Biol. Chem. 277, 44925-44931
40. Riemann, D., Tcherkes, A., Hansen, G. H., Wulfaenger, J., Blosz, T., and Danielsen, E. M. (2005) Functional co-localization of monocytic aminopeptidase N/CD13 with the Fc gamma receptors CD32 and CD64. Biochem. Biophys. Res. Commun. 331, 1408-1412
41. Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Le Trong, I., Teller, D. C., Okada, T., Stenkamp, R. E., Yamamoto, M., and Miyano, M. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739-745
42. Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G., Thian, F. S., Kobilka, T. S., Choi, H. J., Kuhn, P., Weis, W. I., Kobilka, B. K., and Stevens, R. C. (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318, 1258-1265
43. Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., Thompson, J. D., Gibson, T. J., and Higgins, D. G. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948
44. Woodcock, S., Mornon, J. P., and Henrissat, B. (1992) Detection of secondary structure elements in proteins by hydrophobic cluster analysis. Protein Eng. 5, 629-635
45. Sali, A., and Blundell, T. L. (1993) Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779-815
46. Humphrey, W., Dalke, A., and Schulten, K. (1996) VMD: visual molecular dynamics. J. Mol. Graph. 14, 27-38, 33-38
47. Blanpain, C., Vanderwinden, J. M., Cihak, J., Wittamer, V., Le Poul, E., Issafras, H., Stangassinger, M., Vassart, G., Marullo, S., Schlndorff, D., Parmentier, M., and Mack, M. (2002) Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies. Mol. Biol. Cell 13, 723-737
48. Toth, P. T., Ren, D., and Miller, R. J. (2004) Regulation of CXCR4 receptor dimerization by the chemokine SDF-1α and the HIV-1 coat protein gp120: a fluorescence resonance energy transfer (FRET) study. J. Pharmacol. Exp. Ther. 310, 8-17
49. Achour, L., Scott, M. G., Shirvani, H., Thuret, A., Bismuth, G., Labbe-Jullie, C., and Marullo, S. (2009) CD4-CCR5 interaction in intracellular compartments contributes to receptor expression at the cell surface. Blood 113, 1938-1947
50. Allen, S. J., Ribeiro, S., Horuk, R., and Handel, T. M. (2009) Expression, purification and in vitro functional reconstitution of the chemokine receptor CCR1. Protein Expr. Purif. 66, 73-81
51. Tournamille, C., Blancher, A., Le Van Kim, C., Gane, P., Apoil, P. A., Nakamoto, W., Cartron, J. P., and Colin, Y. (2004) Sequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines. Immunogenetics 55, 682-694
52. Issafras, H., Angers, S., Bulenger, S., Blanpain, C., Parmentier, M., Labbe-Jullie, C., Bouvier, M., and Marullo, S. (2002) Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J. Biol. Chem. 277, 34666-34673
53. Angers, S., Salahpour, A., Joly, E., Hilairet, S., Chelsky, D., Dennis, M., and Bouvier, M. (2000) Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl. Acad. Sci. U. S. A. 97, 3684-3689
54. Angers, S., Salahpour, A., and Bouvier, M. (2001) Biochemical and biophysical demonstration of GPCR oligomerization in mammalian cells. Life Sci. 68, 2243-2250
55. Boute, N., Pernet, K., and Issad, T. (2001) Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer. Mol. Pharmacol. 60, 640-645
56. Kenworthy, A. K., and Edidin, M. (1998) Distribution of a glycosylphosphatidylinositol-anchored protein at the apical surface of MDCK cells examined at a resolution of <100 A using imaging fluorescence resonance energy transfer. J. Cell Biol. 142, 69-84
57. Marullo, S., and Bouvier, M. (2007) Resonance energy transfer approaches in molecular pharmacology and beyond. Trends Pharmacol. Sci. 28, 362-365
58. Meyer, B. H., Segura, J. M., Martinez, K. L., Hovius, R., George, N., Johnsson, K., and Vogel, H. (2006) FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells. Proc. Natl. Acad. Sci. U. S. A. 103, 2138-2143
59. James, J. R., Oliveira, M. I., Carmo, A. M., Iaboni, A., and Davis, S. J. (2006) A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer. Nat. Methods 3, 1001-1006
60. Ayoub, M. A., Levoye, A., Delagrange, P., and Jockers, R. (2004) Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers. Mol. Pharmacol. 66, 312-321
61. Percherancier, Y., Berchiche, Y. A., Slight, I., Volkmer-Engert, R., Tamamura, H., Fujii, N., Bouvier, M., and Heveker, N. (2005) Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J. Biol. Chem. 280, 9895-9903
62. Berchiche, Y. A., Chow, K. Y., Lagane, B., Leduc, M., Percherancier, Y., Fujii, N., Tamamura, H., Bachelerie, F., and Heveker, N. (2007) Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and Gαi activation. J. Biol. Chem. 282, 5111-5115
63. Batard, P., Szollosi, J., Luescher, I., Cerottini, J. C., MacDonald, R., and Romero, P. (2002) Use of phycoerythrin and allophycocyanin for fluorescence resonance energy transfer analyzed by flow cytometry: advantages and limitations. Cytometry 48, 97-105
64. Ling, W. L., Longley, R. L., Brassard, D. L., Armstrong, L., and Schaefer, E. J. (2002) Role of integrin alphaVbeta3 in the production of recombinant adenoviruses in HEK-293 cells. Gene Ther. 9, 907-914
65. Jin, Z. H., Josserand, V., Foillard, S., Boturyn, D., Dumy, P., Favrot, M. C., and Coll, J. L. (2007) In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors. Mol. Cancer 6, 41
66. Wang, D., Sun, X., Bohn, L. M., and Sadee, W. (2005) Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer. Mol. Pharmacol. 67, 2173-2184
67. Ayoub, M. A., Maurel, D., Binet, V., Fink, M., Prezeau, L., Ansanay, H., and Pin, J.-P. (2007) Real-time analysis of agonist-induced activation of protease-activated receptor 1/Gαi1 protein complex measured by bioluminescence resonance energy transfer in living cells. Mol. Pharmacol. 71, 1329-1340
68. Vogel, S. S., Thaler, C., and Koushik, S. V. (2006) Fanciful FRET. Sci. STKE 2006, re2
69. Stryer, L., and Haugland, R. P. (1967) Energy transfer: a spectroscopic ruler. Proc. Natl. Acad. Sci. U. S. A. 58, 719-726
70. Boute, N., Boubekeur, S., Lacasa, D., and Issad, T. (2003) Dynamics of the interaction between the insulin receptor and protein tyrosine-phosphatase 1B in living cells. EMBO Rep. 4, 313-319
71. Gales, C., Van Durm, J. J., Schaak, S., Pontier, S., Percherancier, Y., Audet, M., Paris, H., and Bouvier, M. (2006) Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. Nat. Struct. Mol. Biol. 13, 778-786
72. Zhou, J. Y., Toth, P. T., and Miller, R. J. (2003) Direct interactions between the heterotrimeric G protein subunit G beta 5 and the G protein gamma subunit-like domain-containing regulator of G protein signaling 11: gain of function of cyan fluorescent protein-tagged G gamma 3. J. Pharmacol. Exp. Ther. 305, 460-466.
73. Tateyama, M., Abe, H., Nakata, H., Saito, O., and Kubo, Y. (2004) Ligand-induced rearrangement of the dimeric metabotropic glutamate receptor 1α. Nat. Struct. Mol. Biol. 11, 637-642
74. Wynberg, H., Meijer, E. W., Hummelen, J. C., Dekkers, H. P. J. M., Schippers, P. H., and Carlson, A. D. (1980) Circular polarization observed in bioluminescence. Nature 286, 641-642
75. Fredriksson, R., and Schioth, H. B. (2005) The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol. Pharmacol. 67, 1414-1425
76. Bockaert, J., and Pin, J. P. (1999) Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 18, 1723-1729
77. Hanyaloglu, A. C., Seeber, R. M., Kohout, T. A., Lefkowitz, R. J., and Eidne, K. A. (2002) Homo- and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes: differential regulation of beta-arrestins 1 and 2. J. Biol. Chem. 277, 50422-50430
78. Terrillon, S., Durroux, T., Mouillac, B., Breit, A., Ayoub, M. A., Taulan, M., Jockers, R., Barberis, C., and Bouvier, M. (2003) Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol. Endocrinol. 17, 677-691
79. Milligan, G., Wilson, S., and Lopez-Gimenez, J. F. (2005) The specificity and molecular basis of alpha1-adrenoceptor and CXCR chemokine receptor dimerization. J. Mol. Neurosci. 26, 161-168
80. Salahpour, A., and Masri, B. (2007) Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization. Nat. Methods 4, 599-600; author's reply 601
81. Bouvier, M., Heveker, N., Jockers, R., Marullo, S., and Milligan, G. (2007) BRET analysis of GPCR oligomerization: newer does not mean better. Nat. Methods 4, 3-4
82. Hebert, T. E., and Bouvier, M. (1998) Structural and functional aspects of G protein-coupled receptor oligomerization. Biochem. Cell Biol. 76, 1-10
83. Salahpour, A., Angers, S., and Bouvier, M. (2000) Functional significance of oligomerization of G-protein-coupled receptors. Trends Endocrinol. Metab. 11, 163-168
84. Maggio, R., Novi, F., Scarselli, M., and Corsini, G. U. (2005) The impact of G-protein-coupled receptor hetero-oligomerization on function and pharmacology. FEBS J. 272, 2939-2946
85. Springael, J. Y., Urizar, E., Costagliola, S., Vassart, G., and Parmentier, M. (2007) Allosteric properties of G protein-coupled receptor oligomers. Pharmacol. Ther. 115, 410-418
86. Milligan, G. (2001) Oligomerisation of G-protein-coupled receptors. J. Cell Sci. 114, 1265-1271
87. Angers, S., Salahpour, A., and Bouvier, M. (2002) Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42, 409-435
88. Parmentier, M. L., Prezeau, L., Bockaert, J., and Pin, J. P. (2002) A model for the functioning of family 3 GPCRs. Trends Pharmacol. Sci. 23, 268-274
89. Pin, J. P., Kniazeff, J., Goudet, C., Bessis, A. S., Liu, J., Galvez, T., Acher, F., Rondard, P., and Prezeau, L. (2004) The activation mechanism of class-C G-protein coupled receptors. Biol. Cell 96, 335-342 (Pubitemid 38807898)
90. Chabre, M., and le Maire, M. (2005) Monomeric G-proteincoupled receptor as a functional unit. Biochemistry 44, 9395-9403
91. Gurevich, V. V., and Gurevich, E. V. (2008) GPCR monomers and oligomers: it takes all kinds. Trends Neurosci. 31, 74-81
92. Dorsch, S., Klotz, K. N., Engelhardt, S., Lohse, M. J., and Bunemann, M. (2009) Analysis of receptor oligomerization by FRAP microscopy. Nat. Methods 6, 225-230
93. Hern, J. A., Baig, A. H., Mashanov, G. I., Birdsall, B., Corrie, J. E. T., Lazareno, S., Molloy, J. E., and Birdsall, N. J. M. (2010) Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules. Proc. Natl. Acad. Sci. U. S. A. 107, 2693-2698
94. Bayburt, T. H., Leitz, A. J., Xie, G., Oprian, D. D., and Sligar, S. G. (2007) Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins. J. Biol. Chem. 282, 14875-14881
95. Ernst, O. P., Gramse, V., Kolbe, M., Hofmann, K. P., and Heck, M. (2007) Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit. Proc. Natl. Acad. Sci. U. S. A. 104, 10859-10864
96. Whorton, M. R., Bokoch, M. P., Rasmussen, S. G. F., Huang, B., Zare, R. N., Kobilka, B., and Sunahara, R. K. (2007) A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc. Natl. Acad. Sci. U. S. A. 104, 7682-7687
97. Whorton, M. R., Jastrzebska, B., Park, P. S. H., Fotiadis, D., Engel, A., Palczewski, K., and Sunahara, R. K. (2008) Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer. J. Biol. Chem. 283, 4387-4394
98. Chabre, M., Deterre, P., and Antonny, B. (2009) The apparent cooperativity of some GPCRs does not necessarily imply dimerization. Trends Pharmacol. Sci. 30, 182-187
99. Kuszak, A. J., Pitchiaya, S., Anand, J. P., Mosberg, H. I., Walter, N. G., and Sunahara, R. K. (2009) Purification and functional reconstitution of monomeric micro-opioid receptors: allosteric modulation of agonist binding by Gi2. J. Biol. Chem. 284, 26732-26741